Podcasts about cancer screenings

Most health insurance is designed to treat disease after it shows up, not to keep you truly healthy or extend your life. In this video, we explain how longevity medicine and preventive screening can help reduce your risk of heart attacks, cancer, dementia, and other predictable causes of death. We walk through a practical “pyramid” of health: starting with foundations like exercise, VO₂ max, strength, sleep, stress management, and nutrition. From there, we move into regenerative medicine tools such as hormone replacement therapy, testosterone support for men, joint and arthritis treatment, metabolic weight-loss programs, venous circulation care, and sleep apnea treatment. Then we explore advanced preventive screening that goes beyond basic labs, coronary calcium scores, CIMT, full-body MRI, and neuro-quantitative brain scans that can reveal problems years before symptoms appear. Our goal with longevity medicine and preventive screening is not just to add years to your life, but to add quality to those years. We want you to understand your real risks early and know what options exist before a major event occurs.Timestamps:00:00 — Why Health Insurance Doesn't Create Longevity02:10 — Phase 1: Fitness, VO₂ Max & Lifestyle Foundations03:35 — Why Being Fit Makes You Harder to Kill04:15 — Phase 2: Regenerative Medicine & Hormone Therapy06:30 — Weight Loss, Metabolic Health & Lifespan07:30 — Sleep Apnea and 3x Higher Mortality Risk08:15 — Phase 3: Preventing Predictable Causes of Death08:40 — Advanced Heart Screening Beyond Standard Labs09:40 — Full-Body MRI, Cancer Screening & Early Detection10:20 — Brain Imaging and Early Dementia Risk11:55 — Biological Age vs Chronological Age12:30 — Reversing Heart Disease Risk with Data13:10 — Why Knowing Your Risk Early Changes EverythingLearn More: https://www.alluremedical.com/Books & Research: https://www.alluremedical.com/books/Follow Dr. Charles Mok & Allure Medical: LinkedIn: https://www.linkedin.com/in/charles-mok-4a0432114/ Instagram: https://www.instagram.com/alluremedicals/ YouTube: https://www.youtube.com/@AllureMedical TikTok: https://www.tiktok.com/@alluremedicalAmazon Store: https://www.amazon.com/stores/Dr.-Charles-Mok/author/B0791M9FZQInner Circle Membership: https://www.alluremedical.com/inner-circle-membership/Subscribe to the show & leave a 5-star review!#insidethecure

David Raynaud is Senior Manager of Advocacy at the Canadian Cancer Society.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464 Overview: Beyond detecting disease early, lung cancer screening provides an opportunity to encourage smoking cessation. In this episode, we review USPSTF guidelines, compare screening effectiveness, and explore how the use of a pulmonary function test (PFT) and a lung age estimator can help people who smoke better understand their risks and inspire behavior change. Episode resource links: USPSTF: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening BMJ (Clinical Research Ed.). 2008;336(7644):598-600. doi:10.1136/bmj.39503.582396.25. BMC Public Health. 2022;22(1):1164. doi:10.1186/s12889-022-13583-1. Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Rural Health News is a weekly segment of Rural Health Today, a podcast by Hillsdale Hospital. News sources for this episode: Paige Twenter, “‘Withdrawal crisis' strains hospitals in several states: 5 notes,” December 16, 2025, https://www.beckershospitalreview.com/quality/patient-safety-outcomes/withdrawal-crisis-strains-hospitals-in-several-states-5-notes/, Becker's Clinical Leadership. Centers for Disease Control and Prevention, “Notes from the Field: Suspected Medetomidine Withdrawal Syndrome Among Fentanyl-Exposed Patients — Philadelphia, Pennsylvania, September 2024–January 2025,” May 1, 2025, https://www.cdc.gov/mmwr/volumes/74/wr/mm7415a2.htm.  Centers for Disease Control and Prevention, “Drug Overdose in Rural America as a Public Health Issue,” May 16, 2025, https://www.cdc.gov/rural-health/php/public-health-strategy/public-health-considerations-for-drug-overdose-in-rural-america.html. Madeline Ashley, “23 hospital closures in 2025,” November 17, 2025, https://www.beckershospitalreview.com/finance/2-hospital-closures-in-2025/, Becker's Hospital Review. Kell West Regional Hospital, https://www.kellwest.com/. Alyssa Lundy, “Landmark Hospital of Cape Girardeau Announces Closure Due to Unsustainable Healthcare Market Conditions,” September 10, 2025, https://www.landmarkhospitals.com/press, Landmark Hospitals. Dani Anguiano, “Rural US town outraged as only hospital forced to shut: ‘I would have died without it',” October 7, 2025, https://www.theguardian.com/us-news/2025/oct/07/rural-us-town-outraged-as-only-hospital-forced-to-shut-i-would-have-died-without-it, The Guardian. Dennis Thompson, “Experts: Risk-based breast cancer screenings beat annual mammograms,” December 16, 2025, https://www.upi.com/Health_News/2025/12/16/breast-cancer-screenings-risk-based-annual-clinical-trial/5191765896690/, United Press International. Rural Health Today is a production of Hillsdale Hospital in Hillsdale, Michigan and a member of the Health Podcast Network. Our host is JJ Hodshire, our producer is Kyrsten Newlon, and our audio engineer is Kenji Ulmer. Special thanks to our special guests for sharing their expertise on the show, and also to the Hillsdale Hospital marketing team. If you want to submit a question for us to answer on the podcast or learn more about Rural Health Today, visit ruralhealthtoday.com.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-464 Overview: Beyond detecting disease early, lung cancer screening provides an opportunity to encourage smoking cessation. In this episode, we review USPSTF guidelines, compare screening effectiveness, and explore how the use of a pulmonary function test (PFT) and a lung age estimator can help people who smoke better understand their risks and inspire behavior change. Episode resource links: USPSTF: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening BMJ (Clinical Research Ed.). 2008;336(7644):598-600. doi:10.1136/bmj.39503.582396.25. BMC Public Health. 2022;22(1):1164. doi:10.1186/s12889-022-13583-1. Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Lung cancer screening is one of the simplest tools available in cancer care, yet it remains widely underused. A low-dose CT scan takes just a few minutes and can detect lung cancer at its earliest and most treatable stages. Jim Pantelas is a Navy Veteran and a 20 plus year lung cancer survivor. He was diagnosed with stage 3B lung cancer at age 52, back when lung cancer screening was not available. Today, he is joining Dr. Drew Moghanaki, a thoracic oncology leader and VA physician, to deliver a clear message to Veterans and anyone with a smoking history. Get screened. Every year. Key Topics Discussed: How lung cancer can grow with no symptoms until it is advanced Why Veterans may face higher risk from airborne hazards and toxic exposures What screening is like and why it takes less than three minutes Why annual screening matters, not just one scan How early detection expands treatment options and improves outcomes How to access screening through the VA or through civilian healthcare Why screening is covered and cost should not stop you Featured Guests: Jim Pantelas, Navy Veteran, 20 plus Year Lung Cancer Survivor Dr. Drew Moghanaki, UCLA and VA Thoracic Oncology Leader Key Takeaway: Lung cancer is curable when caught early. If you are eligible, start screening at 50 and go every year. Resources mentioned in this episode: PACT Act Benefits and Eligibility: https://www.va.gov/resources/the-pact-act-and-your-va-benefits/ VA Lung Cancer Screening: https://www.prevention.va.gov/preventing_diseases/screening_for_lung_cancer.asp Airborne Hazards and Burn Pit Registry: https://www.publichealth.va.gov/exposures/burnpits/registry.asp LCFA Screening Information: https://lcfamerica.org/about-lung-cancer/detection/screening/  Show Notes | Transcript | Watch Video Hashtags: #LungCancer #VeteransHealth #CancerScreening #EarlyDetection #VAHealthcare #PACTAct #HopeWithAnswers #LCFA

Brian Crombie is joined by Dr. Anna Wilkinson, a family physician with a special interest in oncology and an Associate Professor at the University of Ottawa, for a timely and evidence-based conversation about prostate cancer screening — and why current approaches may need to change. Dr. Wilkinson bridges primary care and oncology, studying how screening guidelines translate into real-world outcomes. In this episode, she explains why prostate cancer screening today looks very different than it did decades ago, and why outdated assumptions may be contributing to rising rates of advanced, incurable disease.Topics discussed include:

Are you wondering whether you need to get a pap smear or colposcopy? Are you wondering whether it's going to be painful or cause other harmful effects in your body? Well, if so, then you're in the right place. I'm Dr. Doni Wilson, a naturopathic doctor as well as a professional midwife and a women's health expert. I've been helping women with abnormal pap smears and high-risk HPV virus for over 25 years, and I'm really glad that you're looking for more information. That tells me you are on the path of taking care of yourself, and that is an essential first step. When it comes to deciding whether to get a pap smear and/or HPV test, keep in mind that these decisions have to do with your age as well as your exposure risk and your past medical history. We're going to talk that through so that you understand exactly, based on your particular situation, whether screening for cervical cancer makes sense at this moment in your life. I'm here to help you! LINKS FROM THE EPISODE:   Sign Up For Your 14-Day Detox: https://doctordoni.com/detox-program   Schedule A Chat With Dr. Doni: https://intakeq.com/new/hhsnib/vuaovx    Read the full episode notes and find more information: https://doctordoni.com/blog/podcasts/ MORE RESOURCES FROM DR. DONI:   Quick links to social media, free guides and programs, and more: https://doctordoni.com/links     Disclosure: Some of the links in this post are product links and affiliate links and if you go through them to make a purchase I will earn a commission at no cost to you. Keep in mind that I link these companies and their products because of their quality and not because of the commission I receive from your purchases. The decision is yours, and whether or not you decide to buy something is completely up to you.

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, Preeti Malani, MD, MSJ, Deputy Editor, and Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for articles published from December 6-12, 2025.

When did you have your last oral cancer screening? The importance of intraoral and the new statistics confirming the significance of the extraoral.  Spend some quality time with Susan Cotten.

Are you aware of your cancer risk factors? In this episode, we delve into lifestyle choices and medical guidelines that can influence the necessity of cancer screenings. Nurse Tina Unsworth simplifies the complexities of risk factors and emphasizes the importance of informed decisions for preventive care. Tune in and empower yourself with the knowledge you need.

Record cold temperatures are impacting parts of the U.S. and the frigid conditions are expected to persist through the weekend. Tom Hanson has more, and Rob Marciano gives the latest forecast. The American Cancer Society is suggesting a change to cervical cancer screening guidelines so women have the option for self-collection of samples. CBS News medical contributor Dr. Céline Gounder explains. A 19-year-old college student said she was on her way home to Texas to surprise her family for Thanksgiving when ICE detained her at Boston Logan International Airport. She was then deported to Honduras despite a judge's order. Jericka Duncan reports. Cincinnati Bengals cornerback Marco Wilson's passion for painting is making a mark. He became the first active player in the NFL to be featured in its Artist Replay program. Wilson sits down with Natalie Morales to talk about art's impact on his life. Amy Allen, who is up for four Grammys, including songwriter of the year, sits down with Anthony Mason to talk about how she went from a nursing student to writing Grammy-nominated hits for Sabrina Carpenter and other pop stars. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Episode Highlights From KatieThe concept of the “Four Horsemen” of chronic disease and why 85% of people over 50 die from one of these conditions.What these diseases share in common: long, silent development over years or decades before symptoms appear.Why traditional screening often catches disease too late. And how new data and AI tools can identify risk far earlier.The difference between 10-year risk scoring and lifetime risk (and why most people never receive the latter).Why cancer screening is age-based rather than risk-based and how this overlooks key early indicators.How AI-driven assessments like Catch use massive datasets to calculate disease risk more accurately than traditional methods.What I learned from my own cancer risk assessment and why it shifted my thinking about proactive health.Why foundational lifestyle inputs (sunlight, vegetables, oily fish, hydration, minerals, sleep, movement, and avoiding chronic inflammation) are more powerful than supplements in reducing long-term disease risk.The connection between allergies, immune signaling, inflammation, and long-term disease patterns.How early lifestyle patterns influence future metabolic, cardiovascular, and cognitive health.Simple, data-backed ways to lower lifelong risk starting today without fear, overwhelm, or chasing expensive solutions.Resources MentionedCatch 

In this episode, Kathy L. MacLaughlin shares clinical insights and practical wisdom as she examines the public health implications of the only FDA-approved self-screening option for cervical cancer screening. After describing the self-screening process, Dr MacLaughlin shows how this option has the potential to expand access, increase the likelihood of early detection, and better meet the needs of patients who face barriers to traditional screening methods. She also addresses concerns about potential false negatives or invalid samples, while highlighting the positive impact self-screening can have on the future of preventative care.Hosted by Omari A. Hodge, MD, FAAFP and Jay-Sheree Allen Akambase, MDCopyright © Society of Teachers of Family Medicine, 2025Resources:Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee - J Low Genit Tract DisUS Preventive Services Task Force (USPSTF)The American Cancer Society Guidelines for the Prevention and Early Detection of Cervical Cancer - American Cancer Society Guest Bio:Dr. Kathy L. MacLaughlin is an Associate Professor of Family Medicine at the Mayo Clinic and a core faculty member of its Family Medicine Residency Program. A clinician researcher and practicing physician, her work focuses on the prevention and early detection of HPV-related cervical cancer, with particular expertise in HPV vaccination, cervical cancer screening, and clinical decision support (CDS) systems. She has served as a co-investigator and principal investigator on multiple NIH- and institutionally funded studies, including trials to increase HPV vaccination uptake and expand access to cervical cancer screening through self-collection methods. Dr. MacLaughlin has contributed to national initiatives as a subject matter expert for the CDC and HRSA and holds key leadership roles with the American Cancer Society's National Roundtable on Cervical Cancer. She has been recognized for her contributions with multiple teaching and research awards, including Family Medicine Teacher of the Year at Mayo Clinic and the MAFP Innovation & Research Award. Her published research spans HPV vaccination, screening disparities, and implementation of CDS tools. Dr. MacLaughlin earned her BA in Philosophy from Luther College and her MD from the University of Minnesota Medical School, completing residency in Family Medicine at Methodist Hospital. Her work reflects a strong commitment to reducing health disparities and advancing evidence-based practices in women's preventive health.Link: https://www.stfm.org/stfmpodcast122025 

YCCI Cultural Ambassador Community Health Watch- Importance of Prostate Cancer Screening by WNHH Community Radio

On this week's news podcast, the former UK prime minister, David Cameron, calls for prostate cancer screening following his diagnosis. But does it really help to know you have the disease? Also, we find out about the DNA composition of the carbon-rich asteroid Bennu, the underlying cause of Santorini's recent earthquakes, and scientists discover where domestic cats came from... Like this podcast? Please help us by supporting the Naked Scientists

We share a practical, clinic‑tested system for hereditary cancer screening that standardizes intake and education, then confront how malpractice pressures distort obstetric decision‑making, fetal monitoring, and access to care. Former ACOG president Dr. Richard Waldman offers data, history, and solutions we can use now.• digital workflow that screens every patient annually from age 18 • video education improving informed consent and test completion • one in four patients meeting hereditary testing criteria • management changes after testing including MRI, meds, referrals • addressing cost and genetic discrimination concerns • OBGYNs as leaders in genetics amid counselor shortages • malpractice landscape, rising verdicts, and physician burnout • neonatal encephalopathy criteria grounding courtroom science • fetal monitoring limits, category II overreaction, cesarean pressure • VBAC safety tied to selection, readiness, and team systems • safety culture, simulation, and checklists reducing riskBe sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on InstagramFollow us on Instagram @thinkingaboutobgyn.

Is it time for an NHS screening programme for prostate cancer? The disease is the most common cancer affecting men in the UK and kills more than 12,000 men every year. A decision is expected to be made by the National Screening Council later this week. Now, former prime minister Lord Cameron has become the latest high-profile figure to reveal his own diagnosis and has called for a national programme to target the groups most at risk. But could an increase in overdiagnosis do more harm than good? Niall is joined by Sky's science and medical correspondent Thomas Moore to discuss. You can find out more information on prostate cancer at www.nhs.uk/conditions/prostate-cancer/ Producer: Araminta Parker Editor: Mike Bovill

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from November 15-21 2025.

In this podcast episode, Paul Limburg, MD, MPH, discusses the movement from academics to industry, developments in colorectal cancer screening tools and more. •    Intro 1:11 •    Paul Limburg, MD, MPH  1:17 •    How did your early influences and childhood years lead you to become interested in gastroenterology and the career you have today?  1:34 •    Who were your early inspirations?  2:14 •    How did you transition from a career in academics and sciences to a life on the commercial side? 3:34 •    How did your role at Exact Sciences come about? 5:58 •    Was it a hard decision to take a new position? 7:47 •    Chey and Limburg on the joy of advancing science and innovation. 9:03 •    Were there any cultural differences that shocked you about the ways work is done in your previous and current positions? 10:10  •    Do you see Exact outsourcing scientific research as the company grows? 12:12 •    What does a typical day look like for you at Exact? […] What are you responsible of as the leading physician? 13:28 •    From a product standpoint, what is ahead on the roadmap for Exact Sciences? […] What are you most excited about regarding next-generation multi-target stool testing and its impact? 15:14 •    How do you respond to gastroenterologists' skepticism and concerns surrounding stool-based screening? 21:15 •    What about addressing the concerns surrounding how we can ensure patients with a positive FIT test go in for a colonoscopy? 23:22 •    How much of an issue are language barriers when it comes to screening tools? 28:11 •    Can you talk about how Exact Sciences are using AI and the evolution of the microbiome internally or in product development? 29:42 •    Do you see a future for stool-based testing in between/in combination with colonoscopies? 32:59 •    Have you noticed differences in sensitivity and specificity based on age? 34:07 •    What are your thoughts on making these tools available in a direct-to-consumer offering? […] How do you make these screening tools more readily available while weighing the usage risks? 35:08 •    What is the rate of patients who have a positive stool-based test getting a colonoscopy? 38:44 •    If you were talking to a GI fellow deciding to make the jump to industry, what do you tell them? 41:58 •    Thank you, Paul 44:55 •    Thanks for listening 45:21 Paul J. Limburg, MD, MPH, is chief medical officer for screening at Exact Sciences and emeritus professor of Medicine at Mayo Clinic.     We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Dr. Limburg, follow @limburg_paul and @ExactSciences on X. Disclosures: Chey and Berry report no relevant financial disclosures. Limburg reports he is an employee of Exact Sciences.

A recent report by the Canadian Cancer Statistics Advisory Committee found that after more than three decades of steady decline, cases of cervical cancer have plateaued in the past 20 years. In an effort to make screening less daunting, the Canadian Cancer Society is pushing for all provinces and territories to replace the traditional pap smear examination with the human papillomavirus (HPV) test. So far, only four provinces have made the switch.But the switch is just a piece of the puzzle. Access to screening, education on reproductive health, and destigmatizing testing all play a role in bringing down cases of cervical cancer - which Canada committed to eliminate by 2040.Host Maria Kestane speaks to Dr. Lucy Gilbert, director of the McGill University Gynecologic Oncology service, and chair of oncology for McGill University's Gerald Bronfman Department of Oncology to discuss the risks related with lack of access to proper screenings, and how Health Canada needs to keep health education top of mind if they want to meet its 2040 goal. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:Through email at hello@thebigstorypodcast.ca Or @thebigstoryfpn on Twitter

Full article: Real-World Use and Outcomes of Lung-RADS v1.1 Category 4B Versus Lung-RADS v2022 Category 0 for Suspected Infectious or Inflammatory Findings on Lung Cancer Screening CT How should radiologists handle suspected infectious or inflammatory findings on lung cancer screening CT? Brittany Miles, MD, talks with Randall Rosenblatt, MD, on the implications of Lung-RADS v2022 category 0 in this setting, based on the recent AJR article by Arora et al.

Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Guest(s): Priyanka Senthil, CEO of American Lung Cancer Screening Initiative and Sam Schwartz, National Director of American Lung Cancer Screening InitiativeTopic: Lung cancer screenings and the upcoming Jackson Stronger Together Community Health FairEmail the show: remedy@mpbonline.org. If you enjoy listening to this podcast, please consider contributing to MPB. https://donate.mpbfoundation.org/mspb/podcast. Hosted on Acast. See acast.com/privacy for more information.

Dr. Caoimhe Hartley, GP with a specialist interest in Women's Health

Dr. Peter Michalos: Early Cancer Screening Can Save Your Life (7 min) Learn more about your ad choices. Visit megaphone.fm/adchoices

Broadcast from KSQD, Santa Cruz on 11-06-2025:>/p> Dr. Dawn interviews Cindy Jackonette and Dr. Michael Alexander about a fundraiser for pancreatic cancer awareness on November 15th at Bargetto Winery from 2-5pm, supporting the Santa Cruz Cancer Benefit Group. Dr. Alexander explains pancreatic cancer has only 10-15% five-year survival rates and is difficult to screen for. Screening involves complex endoscopy procedures examining pancreatic ducts, CT scans and biomarker scans. The disease represents 3% of cancer cases but 8% of deaths. Immune checkpoint inhibitors show limited success except in Lynch syndrome patients with DNA repair defects. The Santa Cruz Cancer Benefit Group donates annually to local cancer organizations and is all volunteer-run with minimal overhead. An emailer asks when her 56-year-old half-African American son should get colon cancer screening given his father and uncle both had the disease. Dr. Dawn explains African Americans have increased risk and recommends immediate colonoscopy despite the ideal screening window being 10 years ago. She emphasizes identifying whether he produces polyps, which would require surveillance every 3-5 years. Unlike pancreatic cancer, colon cancer is highly curable when detected early, with death rates dropping 30-40% since colonoscopies became standard in the mid-1990s. She recommends preventive measures including daily 200mg ibuprofen (if no ulcer history) and a high-fiber diet rich in colorful vegetables containing antioxidants that reduce oxidative stress and DNA damage from free radicals. An emailer from Israel asks about supporting his 38-year-old son's rectal adenocarcinoma treatment. Dr. Dawn recommends nutritional strategies including juicing 10 different fruits and vegetables daily, 20mg melatonin for synergy with chemotherapy, vitamin D supplementation, and L-glutamine as primary food for bowel healing and lymphocyte function. She suggests DHA fish oil to enhance chemotherapy effectiveness, green tea for oncogene inhibition, astragalus herb to increase phagocytic activity and natural killer cells, and rotating water-extracted mushroom formulas with beta-glucans, particularly maitake and shitake. Glutamine also protects mucous membranes from radiation burns. Dr. Dawn discusses alarming cancer rate increases among young adults in Corn Belt states including Iowa, Nebraska, Illinois, Minnesota, Indiana, and Kansas. Since 2015, these states show 5% higher cancer rates for ages 15-49 compared to national averages, with particularly elevated kidney and skin cancer rates. Young women face 66% higher skin cancer risk than peers in other states. . Governor Kim Reynolds invested $1 million for research while Bayer's attempt to shield Roundup from lawsuits failed. Dr. Dawn notes Roundup now contains diquat after removing glyphosate. It has taken decades to accumulate evidence of glyphosates harms, She warns that absence of evidence of Diquats being harmful isn't evidence of safety and that Ames testing suggests high mutation potential. An emailer shares a JAMA article on lithium for Alzheimer's disease. Dr. Dawn explains that calcium dysregulation through NMDA receptors plays an upstream role in Alzheimer's pathology. Lithium, a bipolar disorder treatment, can reset deranged calcium gates, inhibiting mitochondrial damage and tau protein production. She emphasizes tau protein as the true culprit in Alzheimer's while amyloid beta is more symptomatic. Correcting calcium homeostasis allows neuronal autophagy systems to clear waste more efficiently rather than being overwhelmed. She reports dramatic peanut allergy declines following 2017 pediatric recommendations for introducing peanuts at 4-6 months based on the LEAP study showing 81% reduction. Between 2017-2020, peanut allergies dropped from 0.79% to 0.45% of all children under 3, with overall food allergies declining 36%. Studies also show pregnant mothers eating peanuts reduces offspring allergy risk by promoting immune tolerance. We conclude with breakthrough wireless retinal implants for macular degeneration, where cameras on glasses convert images to near-infrared signals to retinal implants which stimulate surviving retinal neurons. The prototype allowed patients to improve by two lines on eye charts and perceive facial expressions and read smaller print.

Prop 50, the redistricting measure aimed at giving Democrats an edge in the midterms next year, is projected to pass. Poway voters appear likely to recall Councilmember Tony Blain over what critics say are unethical actions. UC San Diego Health is the only place in the country offering up a new test for testicular cancer.   What You Need To Know To Start Your Wednesday. 

Detecting Emerald Ash Borer Increasing Cancer Screenings in Kansas Having Healthy Calves   00:01:05 – Detecting Emerald Ash Borer: Shad Hufnagel, Kansas Forest Service forest health coordinator, begins today's show explaining emerald ash borer and how they have identified it in another county in Kansas. KansasForests.org   00:12:05 – Increasing Cancer Screenings in Kansas: The show continues with K-State's Jeff Wichman as he hosts Hope Krebill and Keren Denes-Collar on Sound Living as they discuss cancer screenings and how they hope to provide it to more people. Sound Living   00:23:05 – Having Healthy Calves: K-State dairy specialist Mike Brouk ends the show by saying how producers can boost their bottom line by keeping calves healthy as their value has increased.       Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu.   Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan

Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mutations that cause Tay-Sachs disease and helping families take proactive steps to effectively eliminate the disease in future generations. Matt explains, "So, jscreen is a nonprofit that focuses on providing access to education and high-touch support to individuals, families, and to clinicians in the area of preventive genetics and more specifically for reproductive carrier screening and hereditary cancer screening. "These types of tests actually have been around for a really long time with the advancement in genomic technology and our knowledge generally of genetics. The capabilities we have around these panels—what we can test for and what we can do with them—have grown tremendously over the last two decades. And so, what we're offering now is completely different than what you may have been offered five or 10 years ago." "What I will say is I think that this technology is the most powerful medical intervention that we have. Maybe second to vaccines, which we know obviously can have profound impacts on saving lives, preventive genetics, the ability to screen an individual or a couple or a family, and identify diseases that they may be at risk for, with things that you can do to prevent those diseases from happening or catch them early. That's the holy grail. That's the most amazing thing: being able to intervene."  #jscreen #GeneticTesting #TaySachsDisease #ReproductiveCarrierScreening #HereditaryCancerScreening  jscreen.org Download the transcript here

Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mutations that cause Tay-Sachs disease and helping families take proactive steps to effectively eliminate the disease in future generations. Matt explains, "So, jscreen is a nonprofit that focuses on providing access to education and high-touch support to individuals, families, and to clinicians in the area of preventive genetics and more specifically for reproductive carrier screening and hereditary cancer screening. "These types of tests actually have been around for a really long time with the advancement in genomic technology and our knowledge generally of genetics. The capabilities we have around these panels—what we can test for and what we can do with them—have grown tremendously over the last two decades. And so, what we're offering now is completely different than what you may have been offered five or 10 years ago." "What I will say is I think that this technology is the most powerful medical intervention that we have. Maybe second to vaccines, which we know obviously can have profound impacts on saving lives, preventive genetics, the ability to screen an individual or a couple or a family, and identify diseases that they may be at risk for, with things that you can do to prevent those diseases from happening or catch them early. That's the holy grail. That's the most amazing thing: being able to intervene."  #jscreen #GeneticTesting #TaySachsDisease #ReproductiveCarrierScreening #HereditaryCancerScreening  jscreen.org Listen to the podcast here

Dr. Faisal Khan explains what screening is available for lung cancer, who qualifies for a screening, and how often lung screening appointments should be made.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

"[When] a lot of men think about prostate exams, they immediately think of the glove going on the hand of the physician, and they immediately clench. But really try to talk with them and discuss with them what some of the benefits are of understanding early detection. Even just having those conversations with their providers so that they understand what the risk and benefits are of having screening. And then educate patients on what a prostate-specific antigen (PSA) and digital rectal exam (DRE) actually are—how it happens, what it shows, and what the necessary benefits of those are," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer screening, early detection, and disparities. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 31, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to prostate screening, early detection, and disparities. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ Episode 149: Health Disparities and Barriers in Metastatic Castration-Sensitive Prostate Cancer ONS Voice articles: Gender-Affirming Hormones May Lower PSA and Delay Prostate Cancer Diagnosis in Transgender Women Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients With Genetic Risk Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment Leveling State-Level Tax Policies May Increase Equality in Cancer Screening and Mortality Rates Most Cancer Screening Guidelines Don't Disclose Potential Harms ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses ONS course: Genomic Foundations for Precision Oncology Clinical Journal of Oncology Nursing article: Barriers and Solutions to Cancer Screening in Gender Minority Populations Oncology Nursing Forum articles: Disparities in Cancer Screening in Sexual and Gender Minority Populations: A Secondary Analysis of Behavioral Risk Factor Surveillance System Data Symptom Experiences Among Individuals With Prostate Cancer and Their Partners: Influence of Sociodemographic and Cancer Characteristics Other ONS resources: Genomics and Precision Oncology Learning Library ONS Biomarker Database (refine by prostate cancer) American Cancer Society prostate cancer early detection, diagnosis, and staging page National Institutes of Health prostate cancer screening page U.S. Preventive Services Task Force prostate cancer screening recommendation statement To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "The recommendations are men [aged] 45 who are at high risk, including African American men and men who have a first-degree relative who has been diagnosed with prostate cancer younger than 65 should go through screening. And men aged 40 at an even higher risk, these are the men that have that one first-degree relative who has had prostate cancer before 65. Screening includes the PSA blood test and a digital exam. Those are the screening recommendations, although they are a little bit controversial." TS 3:42 "You still see PSAs and DREs as the first line because they're easier for primary care providers to perform. ... Those are typically covered by insurance, so they still play that role in screening. But with the advent of MRIs and biomarkers, these have really helped refine that screening process and determine treatment options for our patients. Again, those patients who may be at a bit of a higher risk could go for an MRI or have biomarkers completed. Or if they're on that verge with their Gleason score, instead of doing a biopsy, they may send the patient for an MRI or do biomarkers for that patient. ... These updated technologies put [patients] a little bit more at ease that someone's watching what's going on, and they don't have to have anything invasive done to see where they're at with their staging." TS 4:35 "Disparities in screening access exist based on race, socioeconomic status, gender identity, education, and geography. It's really hard in rural areas to get primary care providers or urologists who can actually see these patients, [and] sometimes in urban areas. So socioeconomic status can affect that, but also where a person lives. African American men with lower incomes and people in rural areas face the greatest barriers to receiving screening. It's also important to encourage anyone with a prostate to be screened and offer gender-neutral settings for patients to feel comfortable." TS 7:50 "I think a lot of men feel like if they have no symptoms, they don't have prostate cancer ... so a lot of patients may put off screening because they feel fine, [they] haven't had any urinary symptoms, it doesn't run in their family. ...With prostate cancer, there usually are not symptoms that a patient's having—they may have some urinary issues or some pain—but it's not very frequent that they have that. So, just making sure our patients understand that even though they're not feeling something, it doesn't mean there's not something else going on there." TS 12:53 "Prostate cancer found at an early age can be very curable, so it's really important for men to have those conversations with their providers about the risk and benefits of screening. And anyone that we can help along the way to be able to have those conversations, I think is a great thing for oncology nurses to do." TS 15:44

Will Truheight vitamins really make your kids grow?Where can I learn more about complementary medicine and nutrition?The balls of my feet are sore along with my toes. Is this a vitamin deficiency?

I recently had an ApoB test and am surprised that it isn't lower than it is.  Can you explain?I have an ascending thoracic aortic aneurysm.  How can I keep it from enlarging?Why are you against whole-body scans? Aren't they helpful?Can I take magnesium L-threonate while also taking magnesium glycinate?

Are you up to date on the latest screening techniques for cervical cancer? Credit available for this activity expires: 10/29/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/missed-and-risk-rewriting-cervical-cancer-screening-story-2025a1000t8c?ecd=bdc_podcast_libsyn_mscpedu

Host: Darryl S. Chutka, M.D. Guest: Daniel M. Frendl, M.D., Ph.D. If your practice includes middle age and older men, you've very likely diagnosed prostate cancer. It's the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What's the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I'll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic. Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Riverside Healthcare Imaging Patient Navigator Maureen Elliott discusses what to expect from a CT lung cancer screening and who should schedule an appointment.

SummaryIn this episode, Kimberly and Dr. Julianna Lindsey explore the interconnectedness of emotional and physical health, emphasizing the importance of stability in relationships and the impact of lifestyle choices on overall well-being. They discuss cardiovascular health, the significance of dietary choices, the effects of alcohol, and the role of supplements like glutathione and NAD in promoting longevity. The dialogue highlights the need for self-awareness and critical thinking in navigating health trends and misinformation.FATTY15OFFER: Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/KIMBERLY and using code KIMBERLY at checkout.USE LINK: fatty15.com/KIMBERLYGLOWING GREENS POWDER OFFER: Go to mysolluna.com and use the CODE: PODFAM15 for 15% off your entire order. USE LINK: mysolluna.com CODE: PODFAM15 for 15% off your entire order. Chapters00:00 The Importance of Connection and Stability05:02 Understanding Cardiovascular Health and Screening10:05 Dietary Choices and Their Impact on Health14:54 The Role of Alcohol in Health and Wellness19:41 Exploring Supplements: Glutathione and NAD24:57 Navigating Health Trends and MisinformationSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

While we're making progress in TREATING cancer, worldwide cancer INCIDENCE is soaring, especially among young people; New guidelines for colon cancer screening urge earlier start at age 45; Rates of peanut allergy are declining as more parents follow revised advice to introduce nuts earlier to kids; What's with all the buzz about methylene blue? Legalization and stronger pot are creating an epidemic of ER visits for uncontrolled vomiting, debilitating abdominal pain; New smart toilet gives you a report card on your poop; When Zoloft doesn't work for anxiety.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from October 18-24, 2025.

12:30pm - Brian Duff and Marty Biron talk to Dr. Mary Reed to talk about the importance of cancer screening

Australia has its first new cancer screening programme in 20 years, this time for lung cancer. Today we'll be discussing this new programme in depth as well as the role of primary care and the supports available in delivering the programme.This podcast is Sponsored by the Australian Government National Lung Cancer Screening Program.Professor Vivienne Milch is Medical Director, at Cancer Australia. Professor Milch is also Medical Advisor to the Australian Commonwealth Department of Health, Disability and Ageing on cancer screening policy.Professor Milch holds a Master's degree in Health Policy and is an Adjunct Clinical Associate Professor in the School of Medicine, Sydney Campus at The University of Notre Dame, Australia and Professorial Fellow at the Caring Futures Institute at Flinders University in Adelaide. Prior to joining Cancer Australia, Professor Milch was a General Practitioner and clinical researcher at the Garvan Institute of Medical Research, Sydney. Relevant links: the Investigating Symptoms of Lung Cancer guide Healthcare Provider Toolkit The NLCSP website Program Guidelines GP guide resource Reducing stigma in the program Low-dose CT Scan request form eLearning modules developed by Lung Foundation Australia Actionable additional findings guidelines

Research shows breast cancer is the second leading cause of cancer death in women in the U.S. Data also reveals that in a group of eight women, one will be diagnosed with breast cancer. Additionally, there’s been a growing increase in the number of younger women being diagnosed with breast cancer. According to the Centers for Disease Control and Prevention, at least 27,136 women under the age of 45 were diagnosed with breast cancer in 2022. October marks National Breast Cancer Awareness Month. On Thursday’s edition of “Closer Look,” program host Rose Scott talks with guests about everything from diagnosis to treatment, as well as the importance of younger women participating in clinical research trials. Guests included: Ashley Kennedy, a breast cancer survivor and participant of the 2025 Komen Georgia MORE THAN PINK Walk Theru Ross, the senior program manager of community outreach at Susan G. Komen Dr. Joel Okoli, a professor of surgery in the division of Surgical Oncology at Morehouse School of Medicine Plus, it's the end of an era. EATS, which is regarded as a neighborhood cafeteria, is closing after nearly 33 years. We hear from Robert "Bob" Hatcher, the owner of the eatery known for its meat-and-three format. He reflects on the day the restaurant opened and thanked his customers for making the restaurant part of the community.See omnystudio.com/listener for privacy information.

Greetings Humor Consumers! In this powerful yet hilariously honest episode, Tracy and Cathrine dive into cancer screenings and early detection—a topic most people avoid, ignore, or delay. Tracy opens with her personal breast cancer survival story involving an oncologist, radiation, and a possible perk: a higher, tighter boob.

“Too many women skip mammograms because of pain. But now, there's another option.” — Dr. Margaret Nachtigall  Key Links & Resources  Learn more about Pink Medical and VeraScan HERE   Follow Barbara on Instagram HERE    Contact Barbara: agebetterpodcast@gmail.com  About This Episode  In this episode of AGE BETTER, Barbara is joined by frequent guest Dr. Margaret Nachtigall, reproductive endocrinologist at NYU and Medical Director of Pink Medical. Together, they discuss why mammograms are essential for early detection, why pain has been a barrier for too many women, and how new technology like VeraScan is changing the future of breast cancer screening. They also dive into how hormonal changes affect breast density, the role of genetic testing, and what women of all ages can do to stay proactive about breast health.  Why You Should Listen  Understand why breast cancer screening is still the number one tool for early detection and survival.  Learn how VeraScan offers a painless, compression-free alternative to traditional mammograms.  Discover how hormonal changes — especially around menopause — impact breast density and screening needs.  Hear how genetic testing is being used to personalize breast health care.  Walk away with practical strategies and Dr. Margaret's top takeaways for staying on top of your breast health.  If you're enjoying Age Better, I'd be so grateful if you left a quick review wherever you listen.       And if there's a topic or question you'd love for me to cover in a future episode, send a note to agebetterpodcast@gmail.com -- I love hearing from you!     Learn more about your ad choices. Visit megaphone.fm/adchoices

Read the full show notes on Dr. Aimee's website. Dr. Aimee invites board-certified genetic counselor Natalie Richeimer to discuss the crucial intersection of genetic counseling, IVF, and cancer. Natalie explains the role of genetic counselors in the fertility space, particularly how they assist patients in understanding their risk for genetic conditions stemming from family history, personal health, or ethnicity. Dr. Aimee and Natalie talk about the important work done by JScreen, an organization providing accessible genetic testing for cancer and carrier screening. The conversation highlights the importance of understanding whether cancer is hereditary or sporadic, the implications of genetic predispositions, and how early genetic testing can impact fertility planning and treatment options. Natalie shares insights on the different types of genetic tests available, including those for embryos, and emphasizes the evolving nature and expanding role of genetic testing in family planning. They also discuss common misconceptions about genetic testing, especially among patients with a family history of cancer, and offer practical advice on how to access genetic counseling and testing through JScreen. Read the the full article on Dr. Aimee's site.  JScreen's website JScreen on Instagram Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, October 20, 2025 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

Nurse practitioner Elisabeth Evans discusses her article "The critical role of nurse practitioners in colorectal cancer screening." Elisabeth shares why colorectal cancer is the second-deadliest cancer in the U.S. yet remains under-screened, and why early detection can mean the difference between a 14 percent survival rate and over 90 percent. She highlights the lowered screening age, the role of public figures in raising awareness, and how nurse practitioners and physician associates can normalize conversations, provide multiple screening options, and ease patient fears. Elisabeth also discusses environmental risk factors, the importance of family history, and the potential of emerging technologies like blood-based screening. Listeners will take away strategies to better support patients, improve screening rates, and save lives through prevention and timely intervention. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Lung cancer is one of the world's biggest killers. Today, we explore why, and how medical research into this disease is seeing the development of better diagnostic tools, cancer treatments and even a vaccine to prevent tumours from taking hold in the first place... Like this podcast? Please help us by supporting the Naked Scientists